Skip to main content
Fig. 3 | BMC Genomics

Fig. 3

From: Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients

Fig. 3

11 miRNAs-based risk signature evaluation. a, the Kaplan-meier survival analysis revealed the difference of survival rate between high and low risk group. b, AUC in ROC analysis for 11 DEMs and risk signature at 5-years survival time. c, 1-, 3- and 5-year AUC in ROC analysis. d, Calibration curves of risk signature used for evaluating the 3- and 5- year AUC

Back to article page